Phase 3 COPD Clinical Trials
18 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–18 of 18 trials
Recruiting
Phase 3
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Chronic Obstructive Pulmonary DiseaseCOPD
AstraZeneca82 enrolled13 locationsNCT07566195
Recruiting
Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
COPD, Chronic Obstructive Pulmonary Disease
Haisco Pharmaceutical Group Co., Ltd.376 enrolled1 locationNCT07583849
Recruiting
Phase 3
Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination
PneumoniaCOPD, Chronic Obstructive Pulmonary Diseaseacute coronary syndromes (ACS)
University of Brawijaya60 enrolled1 locationNCT07604103
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled920 locationsNCT06283966
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled301 locationsNCT06883305
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled268 locationsNCT06878261
Recruiting
Phase 3
Reducing Breathlessness With Dronabinol in COPD Patients
COPDBreathlessnessCannabis
Vejle Hospital30 enrolled1 locationNCT06473701
Recruiting
Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Phase 3
Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive (COPD)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.594 enrolled4 locationsNCT07039669
Recruiting
Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
Chronic Obstructive Pulmonary Disease (COPD)
JHSPH Center for Clinical Trials770 enrolled11 locationsNCT06376994
Not Yet Recruiting
Phase 2Phase 3
PRE-TREAT: A clinical trial exploring if a combination inhaler prevents early lung changes from developing into full chronic obstructive pulmonary disease (COPD).
Pre-COPD
The University of Melbourne500 enrolled1 locationACTRN12625000663459
Recruiting
Phase 3
The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD
COPD
Mahidol University50 enrolled1 locationNCT06474039
Recruiting
Phase 3
Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease
COPDCOPD Exacerbation
Guy's and St Thomas' NHS Foundation Trust1,400 enrolled34 locationsNCT06347536
Recruiting
Phase 2Phase 3
"The Effect of Inhaled Nitroglycerin for COPD Patients
COPDCOPD III/IV
Beni-Suef University40 enrolled1 locationNCT06785337
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD
Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.474 enrolled2 locationsNCT06643078
Not Yet Recruiting
Phase 3
A randomised trial of air and oxygen driven nebulised salbutamol and ipratropium in Chronic Obstructive Pulmonary Disease (COPD).
COPD
Medical Research Institute of New Zealand (MRINZ)18 enrolled1 locationACTRN12610000080022
Recruiting
Phase 3
Early inpatient-outpatient hospital-based pulmonary rehabilitation following hospitalisation for acute exacerbations of COPD: a randomised controlled study
Chronic Obstructive Pulmonary Disease (COPD)
Green Lane Research and Educational Fund100 enrolled1 locationACTRN12605000372684
Recruiting
Phase 3
Long term use of azithromycin for chronic lung disease in Aboriginal adults: a randomised controlled trial.
Chronic Obstructive Pulmonary Disease (COPD)
Menzies School of Health Research130 enrolled1 locationACTRN12605000229673